COVID-19 and Clinical Trials: Current Challenges and Future Directions

Author(s): Vinay Singh*, Sandeep Garg, Monika Klimek, Rajeev Ranjan Sinha, Dinesh Dhanwal

Journal Name: Reviews on Recent Clinical Trials

Volume 16 , Issue 3 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: The outbreak of coronavirus disease (COVID-19) has posed a major threat to people's lives across the globe. It has drastically changed the way we perceive this world. A paradigm shift was observed globally as the world’s emphasis shifted to testing, diagnosis, treatment, and developing a coronavirus cure. Clinical trials were also not untouched by this. The coronavirus pandemic has abhorrently affected the day-to-day clinical trial activities at sites.

Methods: The status of various ongoing clinical trials was assessed through a literature search, which also includes clinical trial portals. Our evaluations were based on these observations.

Results: Multiple challenges were present in clinical trials as recruitment, retention, the safety of trial subjects, protocol compliance, and this made the world to re-think to incorporate newer strategies and to cope with this untoward situation.

Conclusion: Digitalization of clinical trials as virtual management of adverse events, remote monitoring visits, and web-based consulting with trial subjects are potential directions that can be applied to better manage clinical trials worldwide.

Keywords: Clinical trials, challenges, coronavirus, COVID-19, strategies, digitalization.

Wu Yi-Chia, Chen Ching-Sunga, Chan Yu-Jiun. The outbreak of COVID-19: An overview. J Chin Med Assoc 2020; 83(3): 217-20.
Hui DS, I, Azhar E, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264-6.
Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17(3): 181-92.
[] [PMID: 30531947]
Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55(3)
[] [PMID: 32081636]
Organization W.H.. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance 2020.
Poongothai S, Anjana RM, Aarthy R, et al. Strategies adopted in conduct of clinical trials amidst coronavirus disease-2019 (COVID-19). J Diabetol 2020; 11: 81-5.
Bhatt A. Clinical trials during the COVID-19 pandemic: Challenges of putting scientific and ethical principles into practice. Perspect Clin Res 2020; 11(2): 59-63.
[] [PMID: 32670829]
CDSCO. Announced clinical trials conduct rules during COVID-19 outbreak
European Medicines Agency. 2020.Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic, Version 3 health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_ covid19_en.pdf
FDA (Food and Drug Administration). FDA guidance on conduct of clinical trials of medical products during COVID19 public health emergency; guidance for industry, investigators, and institutional review boards 2020.
Health Canada Notification on Clinical Trial Management During COVID-19 Pandemic
COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors covid.pdf
Fareed Melhem Medidata. The Global Impact of COVID-19 on Clinical Trials and the Way Forward. Industry Insight 2020.
Crystal M. North, Michael L. Dougan and Chana A. Sacks. Improving Clinical Trial Enrollment- In the Covid-19 Era and Beyond. N Engl J Med 2020; 15(383): 1406-8.
Khanna RC, Cicinelli MV, Gilbert SS, Honavar SG, Murthy GSV. COVID-19 pandemic: Lessons learned and future directions. Indian J Ophthalmol 2020; 68(5): 703-10.
[] [PMID: 32317432]
Baigent C, Harrell FE, Buyse M, Emberson JR, Altman DG. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials 2008; 5(1): 49-55.
[] [PMID: 18283080]
Madhuri P. Remote Site Monitoring: The Future of Clinical Research. Curr Trends Biomedical Eng & Biosci 2017; 9(5)
Muller MP, McGeer A, Straus SE, Hawryluck L, Gold WL. Clinical trials and novel pathogens: lessons learned from SARS. Emerg Infect Dis 2004; 10(3): 389-94.
[] [PMID: 15109402]

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 22 January, 2021
Page: [258 - 261]
Pages: 4
DOI: 10.2174/1574887116666210122160705
Price: $65

Article Metrics

PDF: 436
PRC: 1